Reference health
Fluoropyrimidine-Associated Cardiotoxicity: A Retrospective Case-Control Study
10/10 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 10 checked references that resolve
resolves10.1016/j.clcc.2018.08.001
Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal
resolves10.1016/j.ctrv.2013.03.005
Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors
resolves10.2165/00003495-199957040-00003
Cardiotoxicity of the Antiproliferative Compound Fluorouracil
resolves10.21037/jgo.2017.09.07
Fluoropyrimidine-induced cardiac toxicity: challenging the current paradigm
resolves10.1007/s00432-007-0250-9
Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study
resolves10.1016/j.jacc.2017.09.016
Sex-Related Differences in Vasomotor Function in Patients With Angina and Unobstructed Coronary Arteries
resolves10.1200/JCO.2011.38.5278
Takotsubo Cardiomyopathy and Fluorouracil: Case Report and Review of the Literature
resolves10.1002/cncr.30321
Emergency use of uridine triacetate for the prevention and treatment of life‐threatening 5‐fluorouracil and capecitabine toxicity
resolves10.1158/1078-0432.CCR-04-0169
Thymidylate Synthase Gene Polymorphism Predicts Toxicity in Colorectal Cancer Patients Receiving 5-Fluorouracil-based Chemotherapy
resolves10.1038/clpt.2013.172
Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing
The 1 reference without a DOI — listed, not checked
no DOI — not checkedIn vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1634/theoncologist.2019-0762"><img src="https://citestamp.com/citestamped/10.1634/theoncologist.2019-0762/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1634/theoncologist.2019-0762)